5. CONFLICT OF INTEREST
All members of the EAU Renal Transplantation Guidelines Panel have provided disclosure statements on all relationships that they have that might be perceived to be a potential source of a conflict of interest. This information is summarised below and also publicly accessible through the EAU website: www.uroweb.org/guidelines/.
All members of the Renal Transplantation guidelines working group have provided disclosure statements of all relationships that they have that might be perceived as a potential source of a conflict of interest. This information is provided below and is also publicly available on the EAU website: https://uroweb.org/guidelines/renal-transplantation/panel.
This guidelines document was developed with the financial support of the European Association of Urology. No external sources of funding and support have been involved. The EAU is a non-profit organisation, and funding is limited to administrative and travel and meeting expenses. No honoraria or other reimbursements have been provided.
Disclosures: The EAU Guidelines Office certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/ affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: J.D. Olsburgh reported trial participation for Kings College London. V. Hevia Palacios reported serving as a company consultant for Medtronic Iberia S.A. A. Breda, K. Budde, A. Figueiredo, E. Lledó García, H. Regele, R. Boissier, O. Rodríguez Faba and R.H. Zakri have nothing to declare.